Monday, March 7, 2011

Jazz Pharma earns $24M in Q4, $33M in 2010

Jazz Pharmaceuticals Inc. earned $24.5 million in the December quarter and $32.8 million in 2010.
The Palo Alto company (NASDAQ: JAZZ) had revenue of $53.4 million in the fourth quarter, up from revenue of $38.3 million a year earlier in the same quarter, when it earned $5.7 million.

No comments:

Post a Comment